News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,438 Results
Type
Article (40123)
Company Profile (289)
Press Release (652026)
Section
Business (204563)
Career Advice (2004)
Deals (35497)
Drug Delivery (92)
Drug Development (82048)
Employer Resources (168)
FDA (16277)
Job Trends (14854)
News (346798)
Policy (32728)
Tag
Academia (2544)
Alliances (49468)
Alzheimer's disease (1267)
Approvals (16225)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11617)
Biotechnology (204)
Breast cancer (189)
Cancer (1380)
Cardiovascular disease (116)
Career advice (1671)
Cell therapy (284)
Clinical research (65671)
Collaboration (489)
Compensation (264)
COVID-19 (2565)
C-suite (109)
Data (1403)
Diabetes (174)
Diagnostics (6185)
Earnings (84994)
Employer resources (146)
Events (110895)
Executive appointments (396)
FDA (16955)
Funding (430)
Gene therapy (197)
GLP-1 (642)
Government (4372)
Healthcare (18807)
Infectious disease (2658)
Inflammatory bowel disease (116)
Interviews (313)
IPO (16390)
Job creations (3636)
Job search strategy (1422)
Layoffs (429)
Legal (7908)
Lung cancer (200)
Lymphoma (98)
Manufacturing (210)
Medical device (13236)
Medtech (13241)
Mergers & acquisitions (19267)
Metabolic disorders (476)
Neuroscience (1594)
NextGen Class of 2024 (6544)
Non-profit (4487)
Northern California (1694)
Obesity (272)
Opinion (186)
Patents (118)
People (56636)
Phase I (20419)
Phase II (28909)
Phase III (21560)
Pipeline (517)
Postmarket research (2612)
Preclinical (8655)
Radiopharmaceuticals (237)
Rare diseases (265)
Real estate (5905)
Regulatory (21889)
Research institute (2326)
Resumes & cover letters (349)
Southern California (1469)
Startups (3584)
United States (15223)
Vaccines (569)
Weight loss (201)
Date
Last 7 days (584)
Last 30 days (2264)
Last 365 days (35438)
2024 (35278)
2023 (40317)
2022 (51464)
2021 (55962)
2020 (54318)
2019 (46840)
2018 (35248)
2017 (32309)
2016 (31683)
2015 (37768)
2014 (31552)
2013 (26569)
2012 (28752)
2011 (29490)
2010 (27555)
Location
Africa (719)
Arizona (196)
Asia (37805)
Australia (6169)
California (3823)
Canada (1451)
China (307)
Colorado (172)
Connecticut (177)
Europe (81090)
Florida (541)
Georgia (136)
Illinois (386)
Indiana (225)
Maryland (633)
Massachusetts (2982)
Michigan (173)
Minnesota (290)
New Jersey (1101)
New York (1082)
North Carolina (744)
Northern California (1694)
Ohio (146)
Pennsylvania (926)
South America (1094)
Southern California (1469)
Texas (550)
Utah (108)
Washington State (400)
692,438 Results for "ora inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons
Ora, Inc. announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology 2024 conference, and as host and convener of the Dry Horizons Symposium in partnership with Ophthalmology Innovation Source.
May 1, 2024
·
5 min read
Genetown
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally
Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.
May 2, 2024
·
6 min read
BioMidwest
OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical
OrthoPediatrics Corp. announced the Company has entered into an exclusive Distribution Agreement with Ora Medical, based in Montreal, to sell Ora Medical’s gait trainer, The Levity, a device designed for children with walking difficulties.
November 6, 2023
·
2 min read
Business
Ora, Inc. Appoints Nate Speicher as Chief Financial Officer
Ora, Inc. , the world’s leading Clinical Research Organization (CRO) for ophthalmology pharmaceutical and device development, announced today that Nate Speicher has been appointed Chief Financial Officer (CFO).
June 28, 2023
·
3 min read
Genetown
Ora, Inc. Partners with the North West London Clinical Trials Alliance to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments
Ora, Inc. announced its partnership with the North West London Clinical Trials Alliance, a collaboration between clinical trial teams that aims to improve access to and the quality of clinical research in the region.
July 12, 2023
·
4 min read
Press Releases
Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference
December 16, 2024
·
2 min read
Deals
Oragenics, Inc. Announces Pricing of Public Offering
Oragenics, Inc. today announced that it has entered into a placement agency agreement for the purchase and sale of 1,100,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price of $1.00 per share.
June 25, 2024
·
3 min read
BioMidwest
Oragenics, Inc. Announces Proposed Public Offering - June 24, 2024
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced that it intends to offer and sell shares of its common stock.
June 24, 2024
·
3 min read
BioMidwest
Oragenics, Inc. Announces Closing of Public Offering - June 26, 2024
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced the closing of its public offering of 1,100,000 shares of its common stock at an offering price of $1.00 per share.
June 26, 2024
·
3 min read
Deals
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
Oragenics, Inc. today announced that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated June 18, 2024, notifying the Company that it has accepted the Company’s plan to regain compliance with NYSE American’s continued listing standards.
June 20, 2024
·
2 min read
1 of 69,244
Next
